<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04970706</url>
  </required_header>
  <id_info>
    <org_study_id>M2017401</org_study_id>
    <nct_id>NCT04970706</nct_id>
  </id_info>
  <brief_title>Cartilage Injury and Remodeling After ACL Rupture and Reconstruction: Functional Imaging and Biomarkers</brief_title>
  <official_title>Longitudinal Assessment of Cartilage Injury and Remodeling After Anterior Cruciate Ligament Rupture and Reconstruction: A Correlational Study of Functional Imaging and Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will establish novel relationships between intra-articular MSC&#xD;
      recruitment, synovial inflammation, biomarkers of cartilage degeneration and joint&#xD;
      inflammation, clinical patient factors, and downstream alterations in cartilage composition&#xD;
      and morphology to provide novel insights into the pathoetiology of PTOA after ACL injury and&#xD;
      reconstruction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In efforts to study the pathoetiology of post-traumatic osteoarthritis (PTOA), we propose a&#xD;
      collaborative, prospective cohort study of 38 patients undergoing primary anterior cruciate&#xD;
      ligament (ACL) reconstruction after ACL rupture. We will assess the longitudinal progression&#xD;
      of patient-reported outcomes, knee laxity, MRI-based articular cartilage morphology and&#xD;
      composition, and serum-borne biomarkers of cartilage degeneration up to 1 year of follow-up.&#xD;
      Furthermore, stem cell mobilization, chemokine and pro-inflammatory cytokine concentrations,&#xD;
      and inflammatory cell recruitment into synovial tissue will be measured from&#xD;
      intraoperatively-collected samples. We will perform mixed multivariate linear regression&#xD;
      modeling to elucidate potentially novel relationships between patient demographics, anatomy,&#xD;
      biological factors, and downstream alterations in articular cartilage morphology and&#xD;
      composition. We request $200,000 in funding over a two-year duration.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Objectives measure of knee stability</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Knee stability (anterior-posterior laxity) will be measured utilizing the KT-2000 arthrometer, based on the side-to-side difference (SSD) observed between the injured and the healthy, contralateral knee. Subjects will be tested at 90 days, 180 days, and 1 year after surgery, with maximum manual force performed at 30 and 90 degrees of knee flexion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMP</measure>
    <time_frame>12 months after operation</time_frame>
    <description>Cartilage Biomarker Analysis;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin-1</measure>
    <time_frame>12 months after operation</time_frame>
    <description>Chemokines and Pro-Inflammatory Cytokines in Synovial Fluid;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MMP-1</measure>
    <time_frame>12 months after operation</time_frame>
    <description>Soft Tissue Protease and Protease Inhibitor Analysis in Synovial Fluid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>colony-forming units (CFU)</measure>
    <time_frame>12 months after operation</time_frame>
    <description>The CFU assay is a common means of analyzing MSC concentration in bodily fluids</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cartilage morphology</measure>
    <time_frame>12 months after operation</time_frame>
    <description>Quantitative MRI of cartilage morphology</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnetic resonance imaging</measure>
    <time_frame>12 months after operation</time_frame>
    <description>Quantitative MRI of Cartilage Composition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tegner Activity Scale</measure>
    <time_frame>12 months after operation</time_frame>
    <description>knee evaluation are commonly used to document a patient's activity level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lysholm Knee Scale</measure>
    <time_frame>12 months after operation</time_frame>
    <description>knee evaluation are commonly used to document a patient's functional outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Knee Documentation Committee (IKDC) subjective Scale</measure>
    <time_frame>12 months after operation</time_frame>
    <description>knee evaluation are commonly used to document a patient's functional outcomes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Anterior Cruciate Ligament Injuries</condition>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <description>Volunteers were healthy people without ACL rupture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with ACL Rupture</arm_group_label>
    <description>All patients will undergo a standardized single-bundle technique with a hamstring or bone-patellar tendon-bone autograft.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ACL reconstruction</intervention_name>
    <description>All patients will undergo a standardized single-bundle technique with a hamstring or bone-patellar tendon-bone autograft.</description>
    <arm_group_label>Patients with ACL Rupture</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participating physicians at each site will identify potential subjects from their&#xD;
        clinics' patients according to the inclusion/exclusion criteria listed below. Based on&#xD;
        surgical volumes at both sites, patients generally undergo ACL reconstruction 8-12 weeks&#xD;
        after initial screening. In the preoperative timeframe, all patients will undergo standard&#xD;
        physical therapy to address pain, swelling, and motion deficits, as is standard of care at&#xD;
        both institutions.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - Males and females, aged 18 - 30 years&#xD;
&#xD;
          -  Isolated, traumatic primary anterior cruciate ligament rupture requiring surgical&#xD;
             reconstruction&#xD;
&#xD;
          -  Surgical reconstruction performed using a single-bundle technique utilizing an&#xD;
             autograft&#xD;
&#xD;
          -  No history of ipsilateral traumatic knee injury or fracture&#xD;
&#xD;
          -  No evidence of PCL injury or more than grade 1 injury to the MCL or LCL&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - BMI &lt; 18.5 or &gt;35 kg/m2&#xD;
&#xD;
          -  Injury occurred longer than 4 weeks before enrollment&#xD;
&#xD;
          -  Intra-articular steroid injection within 3 months of injury&#xD;
&#xD;
          -  Chondral defects greater than 3 cm2 or Outerbridge grade II or higher lesions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yingfang ao, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>yanfang jiang, Msc.</last_name>
    <phone>15011420759</phone>
    <email>anthea_jiang@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking university third hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yanfang jiang, MSc.</last_name>
      <phone>15011420759</phone>
      <email>anthea_jiang@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

